Gout drug may reduce risk of death

In a recently to be published study in Annals of the Rheumatic Diseases, researchers have found the use of the drug allopurinol was associated with a reduced risk of death in hyperuricemic (gout) patients. The study, the first in a general population, has found the overall benefit of allopurinol on survival may outweigh the impact of rare serious adverse effects.Researchers from the Section of Rheumatology and Clinical Epidemiology at Boston University School of Medicine (BUSM) contributed to this study.Gout has been associated with an increased risk of premature death.
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Gout Source Type: news